Koxma Tag Syrup
Prescription Required
Product introduction
Koxma Tag Syrup is a pain relieving medicine. It is used to treat moderate to severe pain. It gives prolonged relief from severe pain for up to 12 hours.
Koxma Tag Syrup is used for the treatment of moderate to severe pain
Koxma Tag Syrup is used for the treatment of moderate to severe pain
Uses of Koxma Tag Syrup
- Moderate to severe pain
Benefits of Koxma Tag Syrup
In Moderate to severe pain
Koxma Tag Syrup helps to relieve moderate to severe pain in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis. Taking it will help you go about your daily life more easily. This will help you to go about your daily activities more easily and have a better, more active, quality of life. Consult a doctor if you are not sure.
Side effects of Koxma Tag Syrup
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Koxma Tag
- Dizziness
- Sleepiness
- Vomiting
- Nausea
- Constipation
- Sweating
- Lightheadedness
- Sedation
How to use Koxma Tag Syrup
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Koxma Tag Syrup may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Koxma Tag Syrup.
Pregnancy
CONSULT YOUR DOCTOR
Koxma Tag Syrup may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Koxma Tag Syrup is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
If the mother is taking Koxma Tag Syrup, sleepiness of the baby should be monitored.
If the mother is taking Koxma Tag Syrup, sleepiness of the baby should be monitored.
Driving
UNSAFE
Koxma Tag Syrup may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
Koxma Tag Syrup should be used with caution in patients with kidney disease. Dose adjustment of Koxma Tag Syrup may be needed. Please consult your doctor.
Use of Koxma Tag Syrup is not recommended in patients with severe kidney disease.
Use of Koxma Tag Syrup is not recommended in patients with severe kidney disease.
Liver
CAUTION
Koxma Tag Syrup should be used with caution in patients with liver disease. Dose adjustment of Koxma Tag Syrup may be needed. Please consult your doctor.
Use of Koxma Tag Syrup is not recommended in patients with severe liver disease.
Use of Koxma Tag Syrup is not recommended in patients with severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Use Koxma Tag Syrup as instructed by your doctor. Never take in greater amounts or more often than prescribed.
- It causes sleepiness or drowsiness. If this happens to you, do not drive or use machinery.
- Avoid consuming alcohol when taking the Koxma Tag Syrup, as it may cause excessive sleepiness or drowsiness.
- Inform your doctor if you have ever been diagnosed with kidney or liver problems.
- Store opioid pain relievers in a safe place and out of reach of others.
Fact Box
Chemical Class
Phenanthrenes Derivative
Habit Forming
Yes
Therapeutic Class
PAIN ANALGESICS
Action Class
Opioids
Patient concerns
FAQs
Is there anything I need to be careful about while on therapy with Koxma Tag Syrup?
Koxma Tag Syrup may cause drowsiness and dizziness, especially in the beginning of the treatment. Do not drive or work with tools or machinery if your alertness is affected. It is not advisable to drink alcohol during treatment with this medicine as it might increase sleepiness.
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Schumacher MA, Basbaum AI, Way WL. Opioids Analgesics & Antagonists. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 545.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 939-40.
Marketer details
Name: West-Coast Pharmaceutical Works Ltd
Address: Meldi Estate, Near Prasang Party, Sayona City, Road, Gota, Ahmedabad, Gujarat 382481
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present